Clinical Trial Update: Trial of 4-regimen (SP, FL/Tax, FL/Doc, FOLFOX) in Patients With Recurrent or Metastatic Gastric Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating four regimens (SP, FL/Tax, FL/Doc, and FOLFOX) in recurrent or metastatic gastric cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer

Drugs mentioned

• Adrucil (5-fluorouracil)
• CISPLATIN (cisplatin)
• Eloxatin (oxaliplatin)
• Leucovorin (folinic acid)
• PACLITAXEL (PACLITAXEL)
• S-1 (tegafur/gimeracil/oteracil)
• Taxotere (docetaxel)

Snippet

Sponsor: Yonsei University | Conditions: Recurrent or Metastatic Gastric Cancer | Phase 2 | Status: COMPLETED